Literature DB >> 22433584

Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease.

Giselli Scaini1, Brena P Teodorak, Isabela C Jeremias, Meline O Morais, Francielle Mina, Diogo Dominguini, Bruna Pescador, Clarissa M Comim, Patrícia F Schuck, Gustavo C Ferreira, João Quevedo, Emilio L Streck.   

Abstract

Maple syrup urine disease (MSUD) is an autosomal recessive metabolic disorder resulting from deficiency of branched-chain α-keto acid dehydrogenase complex leading to branched chain amino acids (BCAA) leucine, isoleucine, and valine accumulation as well as their corresponding transaminated branched-chain α-keto acids. MSUD patients present neurological dysfunction and cognitive impairment. Here, we investigated whether acute and chronic administration of a BCAA pool causes impairment of acquisition and retention of avoidance memory in young rats. We have used two administration protocols. Acute administration consisted of three subcutaneous administrations of the BCAA pool (15.8 μL/g body weight at 1-h intervals) containing 190 mmol/L leucine, 59 mmol/L isoleucine, and 69 mmol/L valine or saline solution (0.85% NaCl; control group) in 30 days old Wistar rats. Chronic administration consisted of two subcutaneous administrations of BCAA pool for 21 days in 7 days old Wistar rats. N-acetylcysteine (NAC; 20 mg/kg) and deferoxamine (DFX; 20 mg/kg) co administration influence on behavioral parameters after chronic BCAA administration was also investigated. BCAA administration induced long-term memory impairment in the inhibitory avoidance and CMIA (continuous multiple-trials step-down inhibitory avoidance) tasks whereas with no alterations in CMIA retention memory. Inhibitory avoidance alterations were prevented by NAC and DFX. BCAA administration did not impair the neuropsychiatric state, muscle tone and strength, and autonomous function evaluated with the SHIRPA (SmithKline/Harwell/ImperialCollege/RoyalHospital/Phenotype Assessment) protocol. Taken together, our results indicate that alterations of motor activity or emotionality probably did not contribute to memory impairment after BCAA administration and NAC and DFX effects suggest that cognition impairment after BCAA administration may be caused by oxidative brain damage.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22433584     DOI: 10.1016/j.bbr.2012.03.004

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  15 in total

1.  Antioxidants reverse the changes in energy metabolism of rat brain after chronic administration of L.-tyrosine.

Authors:  Brena P Teodorak; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Letícia J Teixeira; Joyce Rebelo; Samira D T De Prá; Neila Zeni; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2016-12-06       Impact factor: 3.584

2.  Acute Administration of Branched-Chain Amino Acids Increases the Pro-BDNF/Total-BDNF Ratio in the Rat Brain.

Authors:  Giselli Scaini; Meline O S Morais; Camila B Furlanetto; Luiza W Kist; Talita C B Pereira; Patrícia F Schuck; Gustavo C Ferreira; Matheus A B Pasquali; Daniel P Gelain; José Cláudio F Moreira; Maurício R Bogo; Emilio L Streck
Journal:  Neurochem Res       Date:  2015-02-14       Impact factor: 3.996

3.  Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors.

Authors:  Luciane Taschetto; Giselli Scaini; Hugo G Zapelini; Ândrea C Ramos; Giulia Strapazzon; Vanessa M Andrade; Gislaine Z Réus; Monique Michels; Felipe Dal-Pizzol; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2017-05-27       Impact factor: 3.584

4.  Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.

Authors:  Emilio L Streck; Felipe P Bussular; Leticia B Wessler; Mariane B Duarte; Victoria L Rezende; Matheus S Rodrigues; Carolina A Torres; Isabela S Lemos; Gabriela Candiotto; Fernanda F Gava; Jade de Oliveira; Samira S Valvassori
Journal:  Metab Brain Dis       Date:  2020-10-24       Impact factor: 3.584

Review 5.  "Classical organic acidurias": diagnosis and pathogenesis.

Authors:  Guglielmo Rd Villani; Giovanna Gallo; Emanuela Scolamiero; Francesco Salvatore; Margherita Ruoppolo
Journal:  Clin Exp Med       Date:  2016-09-09       Impact factor: 3.984

6.  Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model.

Authors:  Giselli Scaini; Clarissa M Comim; Giovanna M T Oliveira; Matheus A B Pasquali; João Quevedo; Daniel P Gelain; José Cláudio F Moreira; Patrícia F Schuck; Gustavo C Ferreira; Maurício R Bogo; Emilio L Streck
Journal:  J Inherit Metab Dis       Date:  2012-10-30       Impact factor: 4.982

7.  Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus.

Authors:  Giselli Scaini; Lis Mairá Mello-Santos; Camila B Furlanetto; Isabela C Jeremias; Francielle Mina; Patrícia F Schuck; Gustavo C Ferreira; Luiza W Kist; Talita C B Pereira; Maurício R Bogo; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-04-05       Impact factor: 5.590

8.  Antioxidants Reverse the Changes in the Cholinergic System Caused by L-Tyrosine Administration in Rats.

Authors:  Lara M Gomes; Giselli Scaini; Milena Carvalho-Silva; Maria L Gomes; Fernanda Malgarin; Luiza W Kist; Maurício R Bogo; Eduardo Pacheco Rico; Alexandra I Zugno; Pedro F P Deroza; Gislaine Z Réus; Airam B de Moura; João Quevedo; Gustavo C Ferreira; Patrícia F Schuck; Emilio L Streck
Journal:  Neurotox Res       Date:  2018-02-07       Impact factor: 3.911

Review 9.  Neurological damage in MSUD: the role of oxidative stress.

Authors:  Angela Sitta; Graziela S Ribas; Caroline P Mescka; Alethéa G Barschak; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2013-11-13       Impact factor: 5.046

10.  Intracerebroventricular administration of α-ketoisocaproic acid decreases brain-derived neurotrophic factor and nerve growth factor levels in brain of young rats.

Authors:  Miriam S W Wisniewski; Milena Carvalho-Silva; Lara M Gomes; Hugo G Zapelini; Patrícia F Schuck; Gustavo C Ferreira; Giselli Scaini; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2015-11-20       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.